Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

[up] Up a level
Number of items: 24.

Liu, Rong, Martin, Tracey Amanda ORCID: https://orcid.org/0000-0003-2690-4908, Jordan, Nicola, Ruge, Fiona, Ye, Lin ORCID: https://orcid.org/0000-0002-0303-2409 and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2016. Epithelial protein lost in neoplasm-α (EPLIN-α) is a potential prognostic marker for the progression of epithelial ovarian cancer. International Journal of Oncology 48 (6) , pp. 2488-2496. 10.3892/ijo.2016.3462
file

Martin, Tracey Amanda ORCID: https://orcid.org/0000-0003-2690-4908, Jordan, Nicola, Davies, E. L. and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2016. Metastasis to bone in human cancer is associated with loss of occludin expression. Anticancer Research 36 (3) , pp. 1287-1294.

Liu, Rong, Martin, Tracey Amanda ORCID: https://orcid.org/0000-0003-2690-4908, Jordan, Nicola Jane, Ruge, Fiona, Ye, Lin ORCID: https://orcid.org/0000-0002-0303-2409 and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2015. Metastasis suppressor 1 expression in human ovarian cancer: the impact on cellular migration and metastasis. International Journal of Oncology 47 (4) , pp. 1429-1439. 10.3892/ijo.2015.3121

Liu, Rong, Jordan, Nicola, Martin, Tracey Amanda ORCID: https://orcid.org/0000-0003-2690-4908, Ruge, Fiona, Ye, Lin ORCID: https://orcid.org/0000-0002-0303-2409 and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2015. Metastasis suppressor 1 (MTSS1) expression in human ovarian cancer; the impact on cellular migration and metastasis [Abstract]. Anticancer Research 35 (7) , p. 4342.

Martin, Tracey Amanda ORCID: https://orcid.org/0000-0003-2690-4908, Jordan, Nicola, Meyers, Isaac and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2015. Comparison of blood brain barrier endothelia reveals a differential expression of tight junction proteins [Abstract]. Anticancer Research 35 (7) , pp. 4357-4358.

Lazaro, Glorianne, Smith, Chris, Goddard, Lindy, Jordan, Nicola Jane, McClelland, Richard Andrew, Barrett-Lee, Peter, Nicholson, Robert Ian and Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702 2013. Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response. Endocrine Related Cancer 20 (5) , pp. 691-704. 10.1530/ERC-13-0019

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Baruha, Bedanta, Smith, Chris, Bellerby, Rebecca, Goddard, Lindy, Jordan, Nicola Jane, Poghosyan, Zaruhi ORCID: https://orcid.org/0000-0003-4966-7618, Nicholson, Robert Ian, Barrett-Lee, Peter and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 2012. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan. BMC Cancer 12 , 458. 10.1186/1471-2407-12-458
file

Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Nicholson, Robert Ian, Barrow, Denise, Dutkowski, Carol Mary, Goddard, Lindy, Jordan, Nicola J., McClelland, Richard Andrew, Knowlden, Janice Mary, Francies, Hayley E., Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702 and Hutcheson, Iain Robert 2011. Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance. Hormone Molecular Biology and Clinical Investigation 5 (2) , pp. 67-77. 10.1515/HMBCI.2011.009

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Jordan, Nicola Jane, Smith, Chris, James, M., Morgan, Liam David ORCID: https://orcid.org/0000-0002-7571-6025, Taylor, Kathryn Mary ORCID: https://orcid.org/0000-0002-9576-9490, Green, T. P. and Nicholson, Robert Ian 2009. Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells. Breast Cancer Research and Treatment 115 (1) , pp. 57-67. 10.1007/s10549-008-0058-6

Baruah, Bedanta Prakash, Smith, Chris, Jordan, Nicola Jane, Nicholson, Robert Ian, Robertson, Jane, Barrett-Lee, Peter and Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702 2009. Overexpression of CD44 in acquired endocrine resistant breast cancer modulates erbB activity and promotes an invasive phenotype. Cancer Research 69 (2) , 811S-811S.

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Jordan, Nicola Jane, Morgan, Liam David ORCID: https://orcid.org/0000-0002-7571-6025, Smith, Christopher, Goddard, Lindy, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 and Nicholson, Robert 2009. Adverse features of acquired antihormone resistance and their targeting. Hiscox, Stephen Edward, Gee, Julia Margaret Wendy and Nicholson, Robert, eds. Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer: New Molecular Aspects and their Potential as Targets, London: Springer, pp. 139-160. (10.1007/978-1-4020-8526-0_8)

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Jordan, Nicola Jane, Crandon-Lewis, A., Jiang, W., Nicholson, Robert Ian and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 2009. Overexpression of L1CAM accompanies acquired endocrine resistance and is associated with the development of an aggressive cell phenotype [Abstract]. Cancer Research 69 (2) , 213S-213S. 10.1158/0008-5472.SABCS-3028

Taylor, Kathryn Mary ORCID: https://orcid.org/0000-0002-9576-9490, Vichova, Petra, Jordan, Nicola Jane, Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Hendley, Rhiannon and Nicholson, Robert Ian 2008. ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer cells. Endocrinology 149 (10) , pp. 4912-4920. 10.1210/en.2008-0351

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Goddard, Lindy, Jordan, Nicola Jane, Smith, Chris, Harper, Maureen Elaine, Nicholson, Robert Ian and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 2008. Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1 [Abstract]. Breast Cancer Research 10 (S2) , P34. 10.1186/bcr1918
file

Taylor, Kathryn Mary ORCID: https://orcid.org/0000-0002-9576-9490, Jordan, Nicola JAne, Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 and Nicholson, Robert Ian 2008. Zinc transporter HKE4 as a new target in antihormone resistance of breast cancer [Abstract]. Breast Cancer Research 10 (s2) , P42. 10.1186/bcr1926
file

Khirwadkar, Yamini, Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Jordan, Nicola Jane and Nicholson, Robert Ian 2007. HGF/SF promotes an aggressive phenotype in c-Met-overexpressing fulvestrant-resistant MCF-7 cells - Evidence for MMP-9 and PI3k involvement [Abstract]. Annals of Oncology 18 (S4) , P611. 10.1093/annonc/mdm166

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Jordan, Nicola Jane, Morgan, Liam David ORCID: https://orcid.org/0000-0002-7571-6025, Green, T. P. and Nicholson, Robert Ian 2007. Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells. Clinical & Experimental Metastasis 24 (3) , pp. 157-167. 10.1007/s10585-007-9065-y

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Green, T. P., Smith, Chris, James, M., Jordan, Nicola Jane and Nicholson, Robert Ian 2007. Combination treatment with AZD0530 and tamoxifen prevents acquired antiestrogen resistance in breast cancer cells [Abstract]. Molecular Cancer Therapeutics 6 (Suppl) , 3411S.

Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Jordan, Nicola Jane, Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111, Harper, Maureen Elaine, McClelland, Richard, Smith, Chris and Nicholson, Robert 2006. Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions. Endocrine-Related Cancer 13 (4) , pp. 1085-1099. 10.1677/erc.1.01270

Jordan, Nicola Jane, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Barrow, Denise, Wakeling, A. E. and Nicholson, Robert Ian 2004. Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells. Breast Cancer Research and Treatment 87 (2) , pp. 167-180. 10.1023/B:BREA.0000041623.21338.47

Nicholson, Robert, Hutcheson, Iain Robert, Knowlden, Janice Mary, Jones, Helen E., Harper, Maureen Elaine, Jordan, Nicola Jane, Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Barrow, Denise and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 2004. Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination. Clinical Cancer Research 10 (1) , 346s-354s. 10.1158/1078-0432.CCR-031206

Nicholson, Robert, Hutcheson, Iain Robert, Knowlden, Janice Mary, Britton, David James, Harper, Maureen Elaine, Jordan, Nicola Jane, Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Barrow, Denise and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 2004. Chapter 16: beyond antihormones in the targeted therapy of breast cancer. Ingle, James N. and Dowsett, Mitchell, eds. Endocrine Therapy for Breast Cancer Proceedings of the 2003 Gleneagles Conference, New York: Marcel Dekker, pp. 249-258.

Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Harper, Maureen Elaine, Hutcheson, Iain Robert, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Barrow, Denise, Knowlden, Janice Mary, McClelland, Richard Andrew, Jordan, Nicola Jane, Wakeling, A. E. and Nicholson, Robert Ian 2002. ZD1839 ('Iressa') improves the antitumour activity of tamoxifen ('Nolvadex') and ICI 182, 780 ('Faslodex') in antihormone responsive breast cancer [Abstract]. European Journal of Cancer 38 (S7) , S59. 10.1016/S0959-8049(02)80835-8

Nicholson, Robert Ian, Harper, Maureen Elaine, Hutcheson, Iain Robert, Madden, Tracie-Ann ORCID: https://orcid.org/0000-0001-7880-7873, Barrow, Denise, Knowlden, Janice Mary, Jordan, Nicola Jane, Wakeling, A. E. and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 2001. ZD1839 (Iressa) improves the antitumor activity of tamoxifen (Nolvadex) in antihormone-responsive breast cancer cells [Abstract]. Clinical Cancer Research 7 (S) , 3766S.

This list was generated on Fri Oct 24 10:37:41 2025 BST.


Maintained by Cardiff University IT